Urine-derived induced pluripotent stem cells for non-invasive diagnosis of bladder cancer
Yuan Zhu, Jia Shang, Xin Zhang, Sheng Tu, Gang Li, Shenjuan Li, Hongwei Peng, Haoli Ma, Fangjin Chen, Wan Xiang, Cong Zou, Yu Xiao, Zilin Xu, Kaiyu Qian, Gang Wang · 2026
Read Urine-derived induced pluripotent stem cells for non-invasive diagnosis of bladder cancer by Yuan Zhu, Jia Shang, Xin Zhang, Sheng Tu, Gang Li, Shenjuan Li, Hongwei Peng, Haoli Ma, Fangjin Chen, Wan Xiang, Cong Zou, Yu Xiao, Zilin Xu, Kaiyu Qian, Gang Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13617418.txt.
Description
Yuan Zhu and co-authors review in 2026 a urine-based route to bladder cancer diagnosis. Bladder cancer recurs often, and checking for it usually means invasive scopes. Cells shed into urine can be reprogrammed into stem cells, which may carry patient-specific traces of disease.
The review covers how such cells are made, how faithful their genomes stay, and how they might plug into multi-omics testing. Since reprogramming erases some marks, the authors propose a tiered plan: read chemical marks in the raw urine cells, mutations in the reprogrammed clones, and gene activity in their grown derivatives. They also weigh the approach against faster urine DNA tests and tumor organoids.
Catalog record
| CREATOR | Yuan Zhu, Jia Shang, Xin Zhang, Sheng Tu, Gang Li, Shenjuan Li, Hongwei Peng, Haoli Ma, Fangjin Chen, Wan Xiang, Cong Zou, Yu Xiao, Zilin Xu, Kaiyu Qian, Gang Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |